
Elucid Enrolls First Patient in AI-PREDICT Study to Advance AI-Based Cardiovascular Risk Assessment
Elucid Launches Landmark AI-PREDICT Study to Advance Lesion-Level Cardiovascular Risk Assessment Artificial intelligence is rapidly transforming cardiovascular medicine by enabling clinicians to move beyond traditional methods of assessing heart disease risk. One of the latest initiatives in this evolving field…













